Peer-reviewedLicence not statedBlood
Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma
Related
- An interpretable machine learning model for predicting response to anti-GD2 combined with umbilical cord blood-derived natural killer cell immunotherapy in neuroblastoma
- An immunosuppression imaging gauge prospectively predicts metastatic progression and immunotherapy resistance in breast cancer
- Metastatic lung adenocarcinoma harboring an ERBB2 exon 20 insertion and low-level copy-number gain: hyperprogression after immunotherapy and sequential HER2-directed ADC therapy—a case report
- 683 Single-cell RNA-seq analysis of 9464D-GD2 neuroblastoma reveals immune remodeling after anti-CD40 and epigenetic modifier inhibitor therapy
- CD47 blockade augments anti-GD2 driven phagocytosis in vitro but fails to improve in vivo efficacy in immunocompetent, chemoresistant neuroblastoma preclinical models
BibTeX
@article{pertl2026immunotherapy,
title = {{Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma}},
author = {Ursula Pertl and Harald Wodrich and J. Michael Ruehlmann and Stephen D. Gillies and Holger N. Lode and Ralph A. Reisfeld},
journal = {Blood},
year = {2026},
month = oct,
doi = {10.1182/blood-2002-02-0391},
url = {https://hal.science/hal-05784119v1},
}
RIS
TY - JOUR
TI - Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma
AU - Ursula Pertl
AU - Harald Wodrich
AU - J. Michael Ruehlmann
AU - Stephen D. Gillies
AU - Holger N. Lode
AU - Ralph A. Reisfeld
PY - 2026
DA - 2026/10/07
JO - Blood
DO - 10.1182/blood-2002-02-0391
UR - https://hal.science/hal-05784119v1
SN - 0006-4971
SN - 1528-0020
ER -